07:28 AM EDT, 07/31/2024 (MT Newswires) -- GSK (GSK) reported Q2 core earnings Wednesday of 0.43 British pounds ($0.55) per share, up from 0.39 pounds a year earlier.

Analysts polled by Capital IQ expected 0.39 pounds.

Turnover, or sales, for the quarter ended June 30 was 7.88 billion pounds, up from 7.18 billion pounds a year earlier.

Analysts surveyed by Capital IQ expected 7.49 billion pounds.

For 2024, the drug maker said it now expects core EPs to grow by 10% to 12%, compared with its earlier forecast of 8% to 10%.

Turnover for the year is now expected to grow by 7% to 9%, compared with prior guidance of 5% to 7%.

Additionally, the company said it expects to maintain its quarterly dividend at 0.15 pounds, payable Oct. 10 to shareholders as of Aug. 16.

Shares of the company were down 2.3% in recent Wednesday premarket activity.

Price: 38.86, Change: -0.91, Percent Change: -2.29